IBN Coverage Initiated for MetAlert Inc.
With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leading provider of innovative technology solutions to consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA).
- With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leading provider of innovative technology solutions to consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA).
- This has created a significant market opportunity with very few competitors for MetAlert.
- IBN is uniquely positioned to provide MetAlert the solutions needed to reach a wide audience of investors, journalists and the general public.
- “MetAlert is led by a highly experienced management team and operates in a large and growing global market in terms of both potential revenue and number of users,” states Chris Johnson, Director of Client Solutions for IBN.